ArticleInternational journal of general medicine2022

ATG16L1 is a Potential Prognostic Biomarker and Immune Signature for Osteosarcoma: A Study Based on Bulk RNA and Single-Cell RNA-Sequencing.

Zhaojie Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.